Mesothelioma: An inviting but challenging target for gene therapy

American Journal of Respiratory Cell and Molecular Biology

Volumn 42, Issue 4, 2010, Pages 383-384

  Crystal, Ronald G ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GANCICLOVIR; THYMIDINE KINASE; CANCER VACCINE; COMPLEMENTARY RNA; CYTOKINE;

DIAGNOSTIC ACCURACY; DNA MODIFICATION; EDITORIAL; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HERPES SIMPLEX; HUMAN; INCIDENCE; MESOTHELIOMA; SIMIAN VIRUS 40; TUMOR GENE; VIRAL GENE DELIVERY SYSTEM; ADOPTIVE TRANSFER; ANIMAL; APOPTOSIS; CLINICAL TRIAL; GENE VECTOR; GENETICS; IMMUNOLOGY; LUNG TUMOR; METHODOLOGY; NOTE; PLEURA TUMOR; PROGNOSIS; SUICIDE TRANSGENE; TUMOR SUPPRESSOR GENE; VIRUS;

ADOPTIVE TRANSFER; ANIMALS; APOPTOSIS; CANCER VACCINES; CLINICAL TRIALS AS TOPIC; CYTOKINES; GENE THERAPY; GENES, TRANSGENIC, SUICIDE; GENES, TUMOR SUPPRESSOR; GENETIC VECTORS; HUMANS; LUNG NEOPLASMS; MESOTHELIOMA; PLEURAL NEOPLASMS; PROGNOSIS; RNA, ANTISENSE; VIRUSES;

EID: 77950490706     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2010-0071ED     Document Type: Editorial

References (17)

1. Antman KH. Natural history and epidemiology of malignant mesothelioma. Chest 1993;103:373S-376S.
2. Teta MJ, Mink PJ, Lau E, Sceurman BK, Foster ED. US mesothelioma patterns 1973-2002: indicators of change and insights into background rates. Eur J Cancer Prev 2008;17:525-534.
3. Pisani RJ, Colby TV, Williams DE. Malignant mesothelioma of the pleura. Mayo Clin Proc 1988;63:1234-1244.
4. Crystal RG. Living with asbestos. In: Bernstein E, editor. Medical and health annual Encyclopedia Britannica. Chicago; 1986. pp. 52-69.
5. De LA, Baldi A, Esposito V, Howard CM, Bagella L, Rizzo P, Caputi M, Pass HI, Giordano GG, Baldi F, et al. The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas. Nat Med 1997;3:913-916.
6. Teta MJ, Lau E, Sceurman BK, Wagner ME. Therapeutic radiation for lymphoma: risk ofmalignant mesothelioma. Cancer 2007;109:1432-1438.
7. The Lancet Oncology. Space elevators, tennis racquets, and mesothelioma. Lancet Oncol 2008;9:601.
8. Boutin C, Rey F. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: Diagnosis. Cancer 1993;72:389-393.
9. Hillerdal G. Malignant mesothelioma 1982: review of 4710 published cases. Br J Dis Chest 1983;77:321-343.
10. Aisner J. Current approach to malignant mesothelioma of the pleura. Chest 1995;107:332S-344S.
11. Ong ST, Vogelzang NJ. Chemotherapy in malignant pleural mesothelioma: a review. J Clin Oncol 1996;14:1007-1017. (Pubitemid 26085549)
12. Hwang HC, Smythe WR, Elshami AA, Kucharczuk JC, Amin KM, Williams JP, Litzky LA, Kaiser LR, Albelda SM. Gene therapy using adenovirus carrying the herpes simplex-thymidine kinase gene to treat in vivo models of human malignant mesothelioma and lung cancer. Am J Respir Cell Mol Biol 1995;13:7-16.
13. Crumpacker CS. Ganciclovir. N Engl J Med 1996;335:721-729.
14. Sterman DH, Treat J, Litzky LA, Amin KM, Coonrod L, Molnar-Kimber K, Recio A, Knox L, Wilson JM, Albelda SM, et al. Adenovirusmediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patientswith localizedmalignancy: results of a phase I clinical trial in malignant mesothelioma. Hum Gene Ther 1998;9:1083-1092.
15. Sterman DH, Recio A, Vachani A, Sun J, Cheung L, DeLong P, Amin KM, Litzky LA, Wilson JM, Kaiser LR, et al. Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy. Clin Cancer Res 2005;11:7444-7453.
16. Vachani A, Moon E, Wakeam E, Albelda SM. Gene therapy for mesothelioma and lung cancer. Am J Respir Cell Mol Biol 2010:42:385-393.
17. Crystal RG. Transfer of genes to humans: early lessons and obstacles to success. Science 1995;270:404-410.